Jessica Hagen

The Swiss company’s over-the-counter wrist wearable, which uses optical sensors to gather blood pressure readings, will be available to U.S. consumers in 2026.

The wristband is designed to alleviate essential tremors by modulating the nervous system and restoring motor control.

MAI-DxO AI reportedly diagnosed complex medical cases with over four times higher accuracy than generalist physicians and saved costs.

The acquisition, part of a strategic partnership to accelerate Arcadia's growth and innovation, marks an exit for former investor Peloton Equity.

The sale drew mixed reactions, with some U.S. states supporting it as a privacy measure and others objecting over legal and data concerns.

The private equity firm focused on musculoskeletal care has acquired a majority stake in ImmersiveTouch, a medical XR company for facial and thoracic trauma surgeons.

The Polyphonic AI Fund for Surgery will invest in and provide mentorship to AI-enabled platforms aiming to advance surgical innovation.

The company offers mental healthcare for children and their families and will use the funds to expand its reach.

The announcement comes the same week the pharma giant ended its collaboration with Hims & Hers to sell Wegovy, alleging the company engages in deceptive marketing and illegally sells copycat drugs.